Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$15.8B |
| 2 |
Microsoft
MSFT
|
+$4.11B |
| 3 |
Apple
AAPL
|
+$3.59B |
| 4 |
AstraZeneca
AZN
|
+$2.97B |
| 5 |
NVIDIA
NVDA
|
+$2.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$609M |
| 2 |
Advanced Micro Devices
AMD
|
+$459M |
| 3 |
Qualcomm
QCOM
|
+$390M |
| 4 |
Fiserv Inc
FISV
|
+$386M |
| 5 |
Bloom Energy
BE
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.7% |
| 2 | Consumer Discretionary | 10.36% |
| 3 | Financials | 10.2% |
| 4 | Healthcare | 10.1% |
| 5 | Energy | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Madison Square Garden
MSGS
$9.54B
| $252K | ﹤0.01% |
+784
| New | +$234K |
2026 Q1
0 quarters
|
|
1802
Warby Parker
WRBY
$2.89B
| $251K | ﹤0.01% |
+11,926
| New | +$296K |
2026 Q1
0 quarters
|
|
1803
Dauch Corp
DCH
$1.15B
| $251K | ﹤0.01% |
42,325
+27,401
| +184% | +$191K |
2022 Q3
14 quarters
|
|
1804
Helios Technologies
HLIO
$2.23B
| $250K | ﹤0.01% |
+3,859
| New | +$259K |
2026 Q1
0 quarters
|
|
1805
Kymera Therapeutics
KYMR
$8.71B
| $249K | ﹤0.01% |
+2,988
| New | +$237K |
2026 Q1
0 quarters
|
|
1806
Perella Weinberg Partners
PWP
$1.03B
| $247K | ﹤0.01% |
13,605
-22,703
| -63% | -$446K |
2025 Q4
1 quarter
|
|
1807
CMB.TECH NV
CMBT
$5.01B
| $246K | ﹤0.01% |
+19,420
| New | +$244K |
2026 Q1
0 quarters
|
|
1808
Enviri
NVRI
$548M
| $244K | ﹤0.01% |
12,412
-909
| -7% | -$16.9K |
2023 Q1
12 quarters
|
|
1809
Walker & Dunlop
WD
$1.12B
| $242K | ﹤0.01% |
5,464
-27,926
| -84% | -$1.57M |
2023 Q1
12 quarters
|
|
1810
NCR Voyix
VYX
$1.05B
| $242K | ﹤0.01% |
38,287
+7,892
| +26% | +$69.7K |
2022 Q3
14 quarters
|
|
1811
Mobileye
MBLY
$6.14B
| $242K | ﹤0.01% |
35,225
+16,658
| +90% | +$151K |
2025 Q4
1 quarter
|
|
1812
Tandem Diabetes Care
TNDM
$1.13B
| $242K | ﹤0.01% |
12,615
-16,830
| -57% | -$366K |
2024 Q1
8 quarters
|
|
1813
First Advantage
FA
$3.29B
| $241K | ﹤0.01% |
+20,470
| New | +$250K |
2026 Q1
0 quarters
|
|
1814
DELISTED
Leggett & Platt
LEG
| $240K | ﹤0.01% |
24,274
+2,472
| +11% | +$28.2K |
2024 Q3
6 quarters
|
|
1815
Impinj
PI
$5.36B
| $240K | ﹤0.01% |
2,333
-220
| -9% | -$29.3K |
2025 Q4
1 quarter
|
|
1816
Central Garden & Pet Co Class A
CENTA
$2.27B
| $239K | ﹤0.01% |
+7,370
| New | +$235K |
2026 Q1
0 quarters
|
|
1817
Gibraltar Industries
ROCK
$1.12B
| $239K | ﹤0.01% |
+5,983
| New | +$289K |
2026 Q1
0 quarters
|
|
1818
Dillards
DDS
$10.4B
| $238K | ﹤0.01% |
+416
| New | +$259K |
2026 Q1
0 quarters
|
|
1819
Clean Energy Fuels
CLNE
$331M
| $237K | ﹤0.01% |
95,723
+19,250
| +25% | +$44.9K |
2021 Q2
19 quarters
|
|
1820
Peloton Interactive
PTON
$2.29B
| $236K | ﹤0.01% |
55,010
+40,453
| +278% | +$197K |
2025 Q4
1 quarter
|
|
1821
Brink's
BCO
$4.31B
| $235K | ﹤0.01% |
2,270
+489
| +27% | +$58.6K |
2025 Q4
1 quarter
|
|
1822
UL Solutions
ULS
$14.8B
| $235K | ﹤0.01% |
+2,739
| New | +$216K |
2026 Q1
0 quarters
|
|
1823
BrightView Holdings
BV
$976M
| $234K | ﹤0.01% |
+19,878
| New | +$257K |
2026 Q1
0 quarters
|
|
1824
Terex
TEX
$5.83B
| $234K | ﹤0.01% |
+3,958
| New | +$245K |
2026 Q1
0 quarters
|
|
1825
ServisFirst Bancshares
SFBS
$4.3B
| $234K | ﹤0.01% |
+6,420
| New | +$254K |
2026 Q1
0 quarters
|
|
Similar funds
Amundi's Q1 2026 Portfolio in Review
As of Q1 2026, Amundi held 2,103 positions worth $367B, down 0.24% from $368B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Amundi deployed $17.6B of net new capital in Q1 2026, opening 277 new positions and adding to 1,165 existing holdings. Its largest new stake was TotalEnergies: 207,395,270 shares worth $18.9B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Strategy Inc, an estimated $609M trimmed.
- Amundi's largest Q1 2026 buy was TotalEnergies: 207,395,270 shares worth $18.9B.
- Amundi added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Amundi's biggest Q1 2026 reduction was Strategy Inc, cutting an estimated $609M.
- Amundi fully exited CyberArk in Q1 2026, selling an estimated $344M.
- Amundi's ten largest holdings make up 35% of its $367B portfolio in Q1 2026.
- Amundi opened 277 new positions and closed 91 in Q1 2026.
- Amundi's portfolio value fell 0.24% quarter-over-quarter to $367B.
Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.